# Yellwin

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/yellwin

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Total disclosed funding: $42M
- Latest round: Series B (Jan 12, 2026)
- Investors on record: 9

## About

Based in Beijing, China and founded in 2021, Beijing Yuewei Medical Technology Co., Ltd., trading under the name Yellwin, is a medical device manufacturing company that focuses on surgical medical equipment for coronary heart disease. It was established by the cardiology surgery team of Anzhen Hospital and cardiovascular device industry experts. The company has been recognized as the National High-tech Enterprise and has acquired 50 patents. In January 2026, Yellwin raised approximately CNY 100 million in series B funding from new lead investor Efung Capital, new investor Beishang Capital and new investor Bohai Securities.

The company provides surgical medical equipment for cardiology. Products include cardiac fixators, femoral vein extracorporeal circulation cannula, pulsatile left ventricular assist systems, and coronary scoring systems. Its coronary artery bypass systems are in the entered the experimental production phase, which can be used to improve the evaluation capacity of patient conditions.

The company’s revenue is generated by the research, development and sale of high end medical devices, as well as through the provision of solutions for the entire cardiac surgery process.

The company plans to use the funding to strengthen research and development innovation and market penetration in cardiovascular surgery and other extended fields.

## Funding rounds

- Series B, Jan 12, 2026, $14M — Efung Capital, Bohai Securities, Beishang Capital
- Series A, Apr 3, 2025, $14M — Shunxi Fund
- Series A, Dec 28, 2023, $14M — IDG Capital, South China Venture Capital, Yuanhui Investment, Qichen Capital, Nuoyu Capital

## Investors

- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Series A
- South China Venture Capital (https://capitalatlas.ai/funds/south-china-venture-capital) — Series A
- Yuanhui Investment — Series A
- Qichen Capital (https://capitalatlas.ai/funds/qichen-capital) — Series A
- Nuoyu Capital — Series A
- Shunxi Fund (https://capitalatlas.ai/funds/shunxi-fund) — Series A
- Efung Capital (https://capitalatlas.ai/funds/efung-capital) — Series B
- Bohai Securities — Series B
- Beishang Capital (https://capitalatlas.ai/funds/beishang-capital) — Series B